Abstract
According to the most recent estimates from the Surveillance, Epidemiology and End Results (SEER), 74% of children younger than 20 years of age diagnosed with a central nervous system (CNS) malignancy will become 5-year survivors (Howlader et al. 2012). Current therapy for children with CNS malignancies often includes both surgical resection and a combination of CNS-directed radiation therapy (RT) and chemotherapy. Among survivors of all primary pediatric cancers, survivors of CNS malignancies are at the highest risk for late mortality (Mertens et al. 2001; Taylor and Potish 1985; Dama et al. 2006). Furthermore, survivors of CNS malignancies are at risk for developing subsequent neoplasms and chronic endocrine and neurologic conditions (Neglia et al. 2001; Broniscer et al. 2004; Cardous-Ubbink et al. 2007; Duffner et al. 1998; Devarahally et al. 2003; Peterson et al. 2006; Jenkinson et al. 2004; Hammal et al. 2005; Oeffinger et al. 2006; Packer et al. 2003; Gurney et al. 2003a). Documenting the incidence of and risk factors for these conditions in the second, third, and fourth decades of survival in this aging population is essential as future efforts to reduce late morbidity and mortality through modification and risk stratification of primary therapy, screening and early detection of late effects, and interventions to reduce risk and impact of late effects are dependent on identifying populations at highest risk for poor outcomes. Thus, while 5-year survival has improved, the patterns of late morbidity and mortality after exposure to multimodal therapy are only now being established as this population ages. Future studies will need to identify whether exposure to modern therapies (including focal RT for embryonal CNS tumors in infants, whole ventricular volume RT for germ cell tumors, targeted therapies, and immunotherapy, among others) increases or decreases the risk of long-term morbidity and late mortality compared with patients treated in previous eras (Armstrong et al. 2009a).
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Similar content being viewed by others
References
Acharya S, Sarafoglou K, LaQuaglia M, Lindsley S, Gerald W, Wollner N, Tan C, Sklar C (2003) Thyroid neoplasms after therapeutic radiation for malignancies during childhood or adolescence. Cancer 97(10):2397–2403. https://doi.org/10.1002/cncr.11362
Acharya S, DeWees T, Shinohara ET, Perkins SM (2015) Long-term outcomes and late effects for childhood and young adulthood intracranial germinomas. Neuro-Oncology 17(5):741–746. https://doi.org/10.1093/neuonc/nou311
Ahmed SR, Shalet SM, Campbell RH, Deakin DP (1983) Primary gonadal damage following treatment of brain tumors in childhood. J Pediatr 103(4):562–565
Armstrong GT, Liu Q, Yasui Y, Huang S, Ness KK, Leisenring W, Hudson MM, Donaldson SS, King AA, Stovall M, Krull KR, Robison LL, Packer RJ (2009a) Long-term outcomes among adult survivors of childhood central nervous system malignancies in the Childhood Cancer Survivor Study. J Natl Cancer Inst 101(13):946–958. https://doi.org/10.1093/jnci/djp148
Armstrong GT, Liu Q, Yasui Y, Neglia JP, Leisenring W, Robison LL, Mertens AC (2009b) Late mortality among 5-year survivors of childhood cancer: a summary from the Childhood Cancer Survivor Study. J Clin Oncol 27(14):2328–2338. https://doi.org/10.1200/JCO.2008.21.1425
Armstrong GT, Whitton JA, Gajjar A, Kun LE, Chow EJ, Stovall M, Leisenring W, Robison LL, Sklar CA (2009c) Abnormal timing of menarche in survivors of central nervous system tumors: a report from the Childhood Cancer Survivor Study. Cancer 115(11):2562–2570. https://doi.org/10.1002/cncr.24294
Armstrong GT, Conklin HM, Huang S, Srivastava D, Sanford R, Ellison DW, Merchant TE, Hudson MM, Hoehn ME, Robison LL, Gajjar A, Morris EB (2011a) Survival and long-term health and cognitive outcomes after low-grade glioma. Neuro-Oncology 13(2):223–234. https://doi.org/10.1093/neuonc/noq178
Armstrong GT, Liu W, Leisenring W, Yasui Y, Hammond S, Bhatia S, Neglia JP, Stovall M, Srivastava D, Robison LL (2011b) Occurrence of multiple subsequent neoplasms in long-term survivors of childhood cancer: a report from the childhood cancer survivor study. J Clin Oncol 29(22):3056–3064. https://doi.org/10.1200/JCO.2011.34.6585
Armstrong AE, Gillan E, FJ DM Jr (2014) SMART syndrome (stroke-like migraine attacks after radiation therapy) in adult and pediatric patients. J Child Neurol 29(3):336–341. https://doi.org/10.1177/0883073812474843
Armstrong GT, Chen Y, Yasui Y, Leisenring W, Gibson TM, Mertens AC, Stovall M, Oeffinger KC, Bhatia S, Krull KR, Nathan PC, Neglia JP, Green DM, Hudson MM, Robison LL (2016) Reduction in late mortality among 5-year survivors of childhood cancer. N Engl J Med 374(9):833–842. https://doi.org/10.1056/NEJMoa1510795
Bakker B, Oostdijk W, Bresters D, Walenkamp MJ, Vossen JM, Wit JM (2004) Disturbances of growth and endocrine function after busulphan-based conditioning for haematopoietic stem cell transplantation during infancy and childhood. Bone Marrow Transplant 33(10):1049–1056. https://doi.org/10.1038/sj.bmt.1704481
Bakker B, Oostdijk W, Geskus RB, Stokvis-Brantsma WH, Vossen JM, Wit JM (2007) Growth hormone (GH) secretion and response to GH therapy after total body irradiation and haematopoietic stem cell transplantation during childhood. Clin Endocrinol 67(4):589–597. https://doi.org/10.1111/j.1365-2265.2007.02930.x
Balachandar S, Dunkel IJ, Khakoo Y, Wolden S, Allen J, Sklar CA (2014) Ovarian function in survivors of childhood medulloblastoma: impact of reduced dose craniospinal irradiation and high-dose chemotherapy with autologous stem cell rescue. Pediatr Blood Cancer 62:317–321. https://doi.org/10.1002/pbc.25291
Barnes N, Chemaitilly W (2014) Endocrinopathies in survivors of childhood neoplasia. Front Pediatr 2:101. https://doi.org/10.3389/fped.2014.00101
Bauer R, Ortler M, Seiz-Rosenhagen M, Maier R, Anton JV, Unterberger I (2014) Treatment of epileptic seizures in brain tumors: a critical review. Neurosurg Rev 37(3):381–388.; discussion 388. https://doi.org/10.1007/s10143-014-0538-6
Bayley N, Pinneau SR (1952) Tables for predicting adult height from skeletal age: revised for use with the Greulich-Pyle hand standards. J Pediatr 40(4):423–441
Beckers D, Thomas M, Jamart J, Francois I, Maes M, Lebrethon MC, De Waele K, Tenoutasse S, De Schepper J (2010) Adult final height after GH therapy for irradiation-induced GH deficiency in childhood survivors of brain tumors: the Belgian experience. Eur J Endocrinol 162(3):483–490. https://doi.org/10.1530/EJE-09-0690
Bhatti P, Veiga LH, Ronckers CM, Sigurdson AJ, Stovall M, Smith SA, Weathers R, Leisenring W, Mertens AC, Hammond S, Friedman DL, Neglia JP, Meadows AT, Donaldson SS, Sklar CA, Robison LL, Inskip PD (2010) Risk of second primary thyroid cancer after radiotherapy for a childhood cancer in a large cohort study: an update from the childhood cancer survivor study. Radiat Res 174(6):741–752. https://doi.org/10.1667/RR2240.1
Black DF, Morris JM, Lindell EP, Krecke KN, Worrell GA, Bartleson JD, Lachance DH (2013) Stroke-like migraine attacks after radiation therapy (SMART) syndrome is not always completely reversible: a case series. Am J Neuroradiol 34(12):2298–2303. https://doi.org/10.3174/ajnr.A3602
Bobustuc GC, Baker CH, Limaye A, Jenkins WD, Pearl G, Avgeropoulos NG, Konduri SD (2010) Levetiracetam enhances p53-mediated MGMT inhibition and sensitizes glioblastoma cells to temozolomide. Neuro-Oncology 12(9):917–927. https://doi.org/10.1093/neuonc/noq044
Boulanger JM, Coutts SB, Eliasziw M, Gagnon AJ, Simon JE, Subramaniam S, Sohn CH, Scott J, Demchuk AM (2006) Cerebral microhemorrhages predict new disabling or fatal strokes in patients with acute ischemic stroke or transient ischemic attack. Stroke 37(3):911–914. https://doi.org/10.1161/01.STR.0000204237.66466.5f
Bowers DC, Liu Y, Leisenring W, McNeil E, Stovall M, Gurney JG, Robison LL, Packer RJ, Oeffinger KC (2006) Late-occurring stroke among long-term survivors of childhood leukemia and brain tumors: a report from the Childhood Cancer Survivor Study. J Clin Oncol 24(33):5277–5282. https://doi.org/10.1200/JCO.2006.07.2884
Bowers DC, Nathan PC, Constine L, Woodman C, Bhatia S, Keller K, Bashore L (2013) Subsequent neoplasms of the CNS among survivors of childhood cancer: a systematic review. Lancet Oncol 14(8):e321–e328. https://doi.org/10.1016/S1470-2045(13)70107-4
Brauner R, Czernichow P, Rappaport R (1986) Greater susceptibility to hypothalamopituitary irradiation in younger children with acute lymphoblastic leukemia. J Pediatr 108(2):332
Brauner R, Fontoura M, Zucker JM, Devergie A, Souberbielle JC, Prevot-Saucet C, Michon J, Gluckman E, Griscelli C, Fischer A et al (1993) Growth and growth hormone secretion after bone marrow transplantation. Arch Dis Child 68(4):458–463
Broniscer A, Ke W, Fuller CE, Wu J, Gajjar A, Kun LE (2004) Second neoplasms in pediatric patients with primary central nervous system tumors: the St. Jude Children’s Research Hospital experience. Cancer 100(10):2246–2252
Brownstein CM, Mertens AC, Mitby PA, Stovall M, Qin J, Heller G, Robison LL, Sklar CA (2004) Factors that affect final height and change in height standard deviation scores in survivors of childhood cancer treated with growth hormone: a report from the childhood cancer survivor study. J Clin Endocrinol Metab 89(9):4422–4427
Campen CJ, Kranick SM, Kasner SE, Kessler SK, Zimmerman RA, Lustig R, Phillips PC, Storm PB, Smith SE, Ichord R, Fisher MJ (2012) Cranial irradiation increases risk of stroke in pediatric brain tumor survivors. Stroke 43(11):3035–3040. https://doi.org/10.1161/STROKEAHA.112.661561
Cardous-Ubbink MC, Heinen RC, Langeveld NE, Bakker PJ, Voute PA, Caron HN, van Leeuwen FE (2004) Long-term cause-specific mortality among five-year survivors of childhood cancer. Pediatr Blood Cancer 42(7):563–573
Cardous-Ubbink MC, Heinen RC, Bakker PJ, van den Berg H, Oldenburger F, Caron HN, Voute PA, van Leeuwen FE (2007) Risk of second malignancies in long-term survivors of childhood cancer. Eur J Cancer 43(2):351–362
Carel JC, Eugster EA, Rogol A, Ghizzoni L, Palmert MR, Antoniazzi F, Berenbaum S, Bourguignon JP, Chrousos GP, Coste J, Deal S, de Vries L, Foster C, Heger S, Holland J, Jahnukainen K, Juul A, Kaplowitz P, Lahlou N, Lee MM, Lee P, Merke DP, Neely EK, Oostdijk W, Phillip M, Rosenfield RL, Shulman D, Styne D, Tauber M, Wit JM (2009) Consensus statement on the use of gonadotropin-releasing hormone analogs in children. Pediatrics 123(4):e752–e762. https://doi.org/10.1542/peds.2008-1783
Chemaitilly W, Robison LL (2012) Safety of growth hormone treatment in patients previously treated for cancer. Endocrinol Metab Clin N Am 41(4):785–792. https://doi.org/10.1016/j.ecl.2012.07.002
Chemaitilly W, Sklar CA (2010) Endocrine complications in long-term survivors of childhood cancers. Endocr Relat Cancer 17(3):R141–R159. https://doi.org/10.1677/ERC-10-0002
Chemaitilly W, Trivin C, Adan L, Gall V, Sainte-Rose C, Brauner R (2001) Central precocious puberty: clinical and laboratory features. Clin Endocrinol 54(3):289–294
Chemaitilly W, Li Z, Huang S, Ness KK, Clark KL, Green DM, Barnes N, Armstrong GT, Krasin MJ, Srivastava DK, Pui CH, Merchant TE, Kun LE, Gajjar A, Hudson MM, Robison LL, Sklar CA (2015) Anterior hypopituitarism in adult survivors of childhood cancers treated with cranial radiotherapy: a report from the St Jude Lifetime Cohort Study. J Clin Oncol 33:492–500. https://doi.org/10.1200/JCO.2014.56.7933
Chieng PU, Huang TS, Chang CC, Chong PN, Tien RD, Su CT (1991) Reduced hypothalamic blood flow after radiation treatment of nasopharyngeal cancer: SPECT studies in 34 patients. Am J Neuroradiol 12(4):661–665
Children’s OG (2013) Children’s Oncology Group long-term follow-up guidelines for survivors of childhood, adolescent, and young adult cancer. Children’s Oncology Group. http://www.survivorshipguidelines.org/pdf/LTFUGuidelines_40.pdf
Chrousos GP, Kino T, Charmandari E (2009) Evaluation of the hypothalamic-pituitary-adrenal axis function in childhood and adolescence. Neuroimmunomodulation 16(5):272–283. https://doi.org/10.1159/000216185
Ciaccio M, Gil S, Guercio G, Vaiani E, Alderete D, Palladino M, Warman DM, Rivarola MA, Belgorosky A (2010) Effectiveness of rhGH treatment on adult height in GH-deficient childhood survivors of medulloblastoma. Horm Res Paediatr 73(4):281–286. https://doi.org/10.1159/000284393
Clayton PE, Shalet SM (1991a) Dose dependency of time of onset of radiation-induced growth hormone deficiency. J Pediatr 118(2):226–228
Clayton PE, Shalet SM (1991b) The evolution of spinal growth after irradiation. Clin Oncol (R Coll Radiol) 3(4):220–222
Cohen LE, Gordon JH, Popovsky EY, Sainath NN, Feldman HA, Kieran MW, Gordon CM (2012) Bone density in post-pubertal adolescent survivors of childhood brain tumors. Pediatr Blood Cancer 58(6):959–963. https://doi.org/10.1002/pbc.23300
Conceicao FL, da Costa e Silva A, Leal Costa AJ, Vaisman M (2003) Glucagon stimulation test for the diagnosis of GH deficiency in adults. J Endocrinol Invest 26(11):1065–1070
Constine LS, Woolf PD, Cann D, Mick G, McCormick K, Raubertas RF, Rubin P (1993) Hypothalamic-pituitary dysfunction after radiation for brain tumors. N Engl J Med 328(2):87–94
Dama E, Pastore G, Mosso ML, Ferrante D, Maule MM, Magnani C, Merletti F (2006) Late deaths among five-year survivors of childhood cancer. A population-based study in Piedmont Region, Italy. Haematologica 91(8):1084–1091
Darzy KH, Aimaretti G, Wieringa G, Gattamaneni HR, Ghigo E, Shalet SM (2003) The usefulness of the combined growth hormone (GH)-releasing hormone and arginine stimulation test in the diagnosis of radiation-induced GH deficiency is dependent on the post-irradiation time interval. J Clin Endocrinol Metab 88(1):95–102. https://doi.org/10.1210/jc.2002-021094
Devarahally SR, Severson RK, Chuba P, Thomas R, Bhambhani K, Hamre MR (2003) Second malignant neoplasms after primary central nervous system malignancies of childhood and adolescence. Pediatr Hematol Oncol 20(8):617–625
Dewald-Kaufmann JF, Oort FJ, Meijer AM (2014) The effects of sleep extension and sleep hygiene advice on sleep and depressive symptoms in adolescents: a randomized controlled trial. J Child Psychol Psychiatry 55(3):273–283. https://doi.org/10.1111/jcpp.12157
Di Giannatale A, Morana G, Rossi A, Cama A, Bertoluzzo L, Barra S, Nozza P, Milanaccio C, Consales A, Garre ML (2014) Natural history of cavernous malformations in children with brain tumors treated with radiotherapy and chemotherapy. J Neuro-Oncol 117(2):311–320. https://doi.org/10.1007/s11060-014-1390-9
Di Iorgi N, Napoli F, Allegri AE, Olivieri I, Bertelli E, Gallizia A, Rossi A, Maghnie M (2012) Diabetes insipidus—diagnosis and management. Horm Res Paediatr 77(2):69–84. https://doi.org/10.1159/000336333
Diller L, Chow EJ, Gurney JG, Hudson MM, Kadin-Lottick NS, Kawashima TI, Leisenring WM, Meacham LR, Mertens AC, Mulrooney DA, Oeffinger KC, Packer RJ, Robison LL, Sklar CA (2009) Chronic disease in the Childhood Cancer Survivor Study cohort: a review of published findings. J Clin Oncol 27(14):2339–2355
Douw L, van Dellen E, de Groot M, Heimans JJ, Klein M, Stam CJ, Reijneveld JC (2010) Epilepsy is related to theta band brain connectivity and network topology in brain tumor patients. BMC Neurosci 11:103. https://doi.org/10.1186/1471-2202-11-103
Douw L, de Groot M, van Dellen E, Aronica E, Heimans JJ, Klein M, Stam CJ, Reijneveld JC, Hillebrand A (2013) Local MEG networks: the missing link between protein expression and epilepsy in glioma patients? NeuroImage 75:195–203. https://doi.org/10.1016/j.neuroimage.2013.02.067
Duffner PK, Krischer JP, Horowitz ME, Cohen ME, Burger PC, Friedman HS, Kun LE (1998) Second malignancies in young children with primary brain tumors following treatment with prolonged postoperative chemotherapy and delayed irradiation: a Pediatric Oncology Group study. Ann Neurol 44(3):313–316
Duhem R, Vinchon M, Leblond P, Soto-Ares G, Dhellemmes P (2005) Cavernous malformations after cerebral irradiation during childhood: report of nine cases. Childs Nerv Syst 21(10):922–925. https://doi.org/10.1007/s00381-004-1120-2
Elbornsson M, Gotherstrom G, Bosaeus I, Bengtsson BA, Johannsson G, Svensson J (2012) Fifteen years of GH replacement increases bone mineral density in hypopituitary patients with adult-onset GH deficiency. Eur J Endocrinol 166(5):787–795. https://doi.org/10.1530/EJE-11-1072
Elbornsson M, Gotherstrom G, Bosaeus I, Bengtsson BA, Johannsson G, Svensson J (2013) Fifteen years of GH replacement improves body composition and cardiovascular risk factors. Eur J Endocrinol 168(5):745–753. https://doi.org/10.1530/EJE-12-1083
Engel J Jr, Wiebe S, French J, Sperling M, Williamson P, Spencer D, Gumnit R, Zahn C, Westbrook E, Enos B (2003) Practice parameter: temporal lobe and localized neocortical resections for epilepsy: report of the Quality Standards Subcommittee of the American Academy of Neurology, in association with the American Epilepsy Society and the American Association of Neurological Surgeons. Neurology 60(4):538–547
Ergun-Longmire B, Mertens AC, Mitby P, Qin J, Heller G, Shi W, Yasui Y, Robison LL, Sklar CA (2006) Growth hormone treatment and risk of second neoplasms in the childhood cancer survivor. J Clin Endocrinol Metab 91(9):3494–3498. https://doi.org/10.1210/jc.2006-0656
Follin C, Thilen U, Ahren B, Erfurth EM (2006) Improvement in cardiac systolic function and reduced prevalence of metabolic syndrome after two years of growth hormone (GH) treatment in GH-deficient adult survivors of childhood-onset acute lymphoblastic leukemia. J Clin Endocrinol Metab 91(5):1872–1875. https://doi.org/10.1210/jc.2005-2298
Friedman DL, Whitton J, Leisenring W, Mertens AC, Hammond S, Stovall M, Donaldson SS, Meadows AT, Robison LL, Neglia JP (2010) Subsequent neoplasms in 5-year survivors of childhood cancer: the Childhood Cancer Survivor Study. J Natl Cancer Inst 102(14):1083–1095. https://doi.org/10.1093/jnci/djq238
Garwicz S, Anderson H, Olsen JH, Winther JF, Sankila R, Langmark F, Tryggvadottir L, Moller TR (2012) Late and very late mortality in 5-year survivors of childhood cancer: changing pattern over four decades--experience from the Nordic countries. Int J Cancer 131(7):1659–1666. https://doi.org/10.1002/ijc.27393
Glantz MJ, Cole BF, Forsyth PA, Recht LD, Wen PY, Chamberlain MC, Grossman SA, Cairncross JG (2000) Practice parameter: anticonvulsant prophylaxis in patients with newly diagnosed brain tumors. Report of the Quality Standards Subcommittee of the American Academy of Neurology. Neurology 54(10):1886–1893
Gleeson HK, Shalet SM (2004) The impact of cancer therapy on the endocrine system in survivors of childhood brain tumours. Endocr Relat Cancer 11(4):589–602
Gleeson HK, Stoeter R, Ogilvy-Stuart AL, Gattamaneni HR, Brennan BM, Shalet SM (2003) Improvements in final height over 25 years in growth hormone (GH)-deficient childhood survivors of brain tumors receiving GH replacement. J Clin Endocrinol Metab 88(8):3682–3689
Growth Hormone Researhc Society (2000) Consensus guidelines for the diagnosis and treatment of growth hormone (GH) deficiency in childhood and adolescence: summary statement of the GH Research Society. GH Research Society. J Clin Endocrinol Metab 85 (11):3990–3993. doi:https://doi.org/10.1210/jcem.85.11.6984
Gunn ME, Lahdesmaki T, Malila N, Arola M, Gronroos M, Matomaki J, Lahteenmaki PM (2015) Late morbidity in long-term survivors of childhood brain tumors: a nationwide registry-based study in Finland. Neuro-Oncology 17(5):747–756. https://doi.org/10.1093/neuonc/nou321
Gurney JG, Kadan-Lottick NS, Packer RJ, Neglia JP, Sklar CA, Punyko JA, Stovall M, Yasui Y, Nicholson HS, Wolden S, McNeil DE, Mertens AC, Robison LL (2003a) Endocrine and cardiovascular late effects among adult survivors of childhood brain tumors: Childhood Cancer Survivor Study. Cancer 97(3):663–673
Gurney JG, Ness KK, Stovall M, Wolden S, Punyko JA, Neglia JP, Mertens AC, Packer RJ, Robison LL, Sklar CA (2003b) Final height and body mass index among adult survivors of childhood brain cancer: childhood cancer survivor study. J Clin Endocrinol Metab 88(10):4731–4739
Guthrie GD, Eljamel S (2013) Impact of particular antiepileptic drugs on the survival of patients with glioblastoma multiforme. J Neurosurg 118(4):859–865. https://doi.org/10.3171/2012.10.JNS12169
Haddy N, Mousannif A, Tukenova M, Guibout C, Grill J, Dhermain F, Pacquement H, Oberlin O, El-Fayech C, Rubino C, Thomas-Teinturier C, Le-Deley MC, Hawkins M, Winter D, Chavaudra J, Diallo I, de Vathaire F (2011) Relationship between the brain radiation dose for the treatment of childhood cancer and the risk of long-term cerebrovascular mortality. Brain 134(Pt 5):1362–1372. https://doi.org/10.1093/brain/awr071
Hader WJ, Drovini-Zis K, Maguire JA (2003) Primitive neuroectodermal tumors in the central nervous system following cranial irradiation: a report of four cases. Cancer 97(4):1072–1076
Halle M, Hall P, Tornvall P (2011) Cardiovascular disease associated with radiotherapy: activation of nuclear factor kappa-B. J Intern Med 269(5):469–477. https://doi.org/10.1111/j.1365-2796.2011.02353.x
Ham JN, Ginsberg JP, Hendell CD, Moshang T Jr (2005) Growth hormone releasing hormone plus arginine stimulation testing in young adults treated in childhood with cranio-spinal radiation therapy. Clin Endocrinol 62(5):628–632. https://doi.org/10.1111/j.1365-2265.2005.02272.x
Hammal DM, Bell CL, Craft AW, Parker L (2005) Second primary tumors in children and young adults in the North of England (1968–99). Pediatr Blood Cancer 45(2):155–161
Hansson GK, Libby P (2006) The immune response in atherosclerosis: a double-edged sword. Nat Rev Immunol 6(7):508–519. https://doi.org/10.1038/nri1882
Hawkins MM, Kingston JE, Kinnier Wilson LM (1990) Late deaths after treatment for childhood cancer. Arch Dis Child 65(12):1356–1363
van den Heijkant S, Hoorweg-Nijman G, Huisman J, Drent M, van der Pal H, Kaspers GJ, Delemarre-van de Waal H (2011) Effects of growth hormone therapy on bone mass, metabolic balance, and well-being in young adult survivors of childhood acute lymphoblastic leukemia. J Pediatr Hematol Oncol 33(6):e231–e238. https://doi.org/10.1097/MPH.0b013e31821bbe7a
Hoving S, Heeneman S, Gijbels MJ, te Poele JA, Russell NS, Daemen MJ, Stewart FA (2008) Single-dose and fractionated irradiation promote initiation and progression of atherosclerosis and induce an inflammatory plaque phenotype in ApoE(−/−) mice. Int J Radiat Oncol Biol Phys 71(3):848–857. https://doi.org/10.1016/j.ijrobp.2008.02.031
Howlader N, Noone AM, Krapcho M, Neyman N, Aminou R, Altekruse SF, Kosary CL, Ruhl J, Tatalovich Z, Cho H, Mariotto A, Eisner MP, Lewis DR, Chen HS, Feuer EJ, Cronin KA (eds) (2012) SEER cancer statistics review 1975–2009 (vintage 2009 populations). SEER Cancer Statistics Review (CSR). National Cancer Institute, Bethesda, MD
Hua C, Bass JK, Khan R, Kun LE, Merchant TE (2008) Hearing loss after radiotherapy for pediatric brain tumors: effect of cochlear dose. Int J Radiat Oncol Biol Phys 72(3):892–899. https://doi.org/10.1016/j.ijrobp.2008.01.050
Ibrahim K, Appleton R (2004) Seizures as the presenting symptom of brain tumours in children. Seizure 13(2):108–112
Iwayama H, Kamijo T, Ueda N (2011) Hyperinsulinemia may promote growth without GH in children after resection of suprasellar brain tumors. Endocrine 40(1):130–133. https://doi.org/10.1007/s12020-011-9493-y
Jenkin D (1996) Long-term survival of children with brain tumors. Oncology (Williston Park) 10(5):715–719. discussion 720, 722, 728
Jenkinson HC, Hawkins MM, Stiller CA, Winter DL, Marsden HB, Stevens MC (2004) Long-term population-based risks of second malignant neoplasms after childhood cancer in Britain. Br J Cancer 91(11):1905–1910. https://doi.org/10.1038/sj.bjc.6602226
Johnson AH, Jordan C, Mazewski CM (2009) Off-therapy headaches in pediatric brain tumor patients: a retrospective review. J Pediatr Oncol Nurs 26(6):354–361. https://doi.org/10.1177/1043454209340323
Kenney LB, Cohen LE, Shnorhavorian M, Metzger ML, Lockart B, Hijiya N, Duffey-Lind E, Constine L, Green D, Meacham L (2012) Male reproductive health after childhood, adolescent, and young adult cancers: a report from the Children’s Oncology Group. J Clin Oncol 30(27):3408–3416. https://doi.org/10.1200/JCO.2011.38.6938
Kerkhof M, Dielemans JC, van Breemen MS, Zwinkels H, Walchenbach R, Taphoorn MJ, Vecht CJ (2013) Effect of valproic acid on seizure control and on survival in patients with glioblastoma multiforme. Neuro-Oncology 15(7):961–967. https://doi.org/10.1093/neuonc/not057
Khan RB, Onar A (2006) Seizure recurrence and risk factors after antiepilepsy drug withdrawal in children with brain tumors. Epilepsia 47(2):375–379. https://doi.org/10.1111/j.1528-1167.2006.00431.x
Khan RB, Hunt DL, Thompson SJ (2004) Gabapentin to control seizures in children undergoing cancer treatment. J Child Neurol 19(2):97–101
Khan RB, Hunt DL, Boop FA, Sanford RA, Merchant TE, Gajjar A, Kun LE (2005) Seizures in children with primary brain tumors: incidence and long-term outcome. Epilepsy Res 64(3):85–91. https://doi.org/10.1016/j.eplepsyres.2005.03.007
Khan RB, Boop FA, Onar A, Sanford RA (2006a) Seizures in children with low-grade tumors: outcome after tumor resection and risk factors for uncontrolled seizures. J Neurosurg 104(6 Suppl):377–382. https://doi.org/10.3171/ped.2006.104.6.377
Khan RB, Gutin PH, Rai SN, Zhang L, Krol G, DeAngelis LM (2006b) Use of diffusion weighted magnetic resonance imaging in predicting early postoperative outcome of new neurological deficits after brain tumor resection. Neurosurgery 59(1):60–66.; discussion 60-66. https://doi.org/10.1227/01.NEU.0000219218.43128.FC
Khan RB, Merchant TE, Boop FA, Sanford RA, Ledet D, Onar-Thomas A, Kun LE (2013) Headaches in children with craniopharyngioma. J Child Neurol 28(12):1622–1625. https://doi.org/10.1177/0883073812464817
Krahn LE, Pankratz VS, Oliver L, Boeve BF, Silber MH (2002) Hypocretin (orexin) levels in cerebrospinal fluid of patients with narcolepsy: relationship to cataplexy and HLA DQB1*0602 status. Sleep 25(7):733–736
Kranick SM, Campen CJ, Kasner SE, Kessler SK, Zimmerman RA, Lustig RA, Phillips PC, Beslow LA, Ichord R, Fisher MJ (2013) Headache as a risk factor for neurovascular events in pediatric brain tumor patients. Neurology 80(16):1452–1456. https://doi.org/10.1212/WNL.0b013e31828cf81e
Krueger DA, Wilfong AA, Holland-Bouley K, Anderson AE, Agricola K, Tudor C, Mays M, Lopez CM, Kim MO, Franz DN (2013) Everolimus treatment of refractory epilepsy in tuberous sclerosis complex. Ann Neurol 74(5):679–687. https://doi.org/10.1002/ana.23960
Krysiak R, Gdula-Dymek A, Okopien B (2011) Effect of simvastatin and fenofibrate on cytokine release and systemic inflammation in type 2 diabetes mellitus with mixed dyslipidemia. Am J Cardiol 107(7):1010–1018. e1011. https://doi.org/10.1016/j.amjcard.2010.11.023
Kyrnetskiy EE, Kun LE, Boop FA, Sanford RA, Khan RB (2005) Types, causes, and outcome of intracranial hemorrhage in children with cancer. J Neurosurg 102(1 Suppl):31–35. https://doi.org/10.3171/ped.2005.102.1.0031
Laughton SJ, Merchant TE, Sklar CA, Kun LE, Fouladi M, Broniscer A, Morris EB, Sanders RP, Krasin MJ, Shelso J, Xiong Z, Wallace D, Gajjar A (2008) Endocrine outcomes for children with embryonal brain tumors after risk-adapted craniospinal and conformal primary-site irradiation and high-dose chemotherapy with stem-cell rescue on the SJMB-96 trial. J Clin Oncol 26(7):1112–1118
Lew SM, Morgan JN, Psaty E, Lefton DR, Allen JC, Abbott R (2006) Cumulative incidence of radiation-induced cavernomas in long-term survivors of medulloblastoma. J Neurosurg 104(2 Suppl):103–107. https://doi.org/10.3171/ped.2006.104.2.103
Li FP, Cassady JR, Jaffe N (1975) Risk of second tumors in survivors of childhood cancer. Cancer 35(4):1230–1235
Li Z, Franklin J, Zelcer S, Sexton T, Husein M (2014) Ultrasound surveillance for thyroid malignancies in survivors of childhood cancer following radiotherapy: a single institutional experience. Thyroid 24(12):1796–1805. https://doi.org/10.1089/thy.2014.0132
Link K, Moell C, Garwicz S, Cavallin-Stahl E, Bjork J, Thilen U, Ahren B, Erfurth EM (2004) Growth hormone deficiency predicts cardiovascular risk in young adults treated for acute lymphoblastic leukemia in childhood. J Clin Endocrinol Metab 89(10):5003–5012
Livesey EA, Brook CG (1988) Gonadal dysfunction after treatment of intracranial tumours. Arch Dis Child 63(5):495–500
Livesey EA, Brook CG (1989) Thyroid dysfunction after radiotherapy and chemotherapy of brain tumours. Arch Dis Child 64(4):593–595
Lopez Andreu JA, Fernandez PJ, Ferris i Tortajada J, Navarro I, Rodriguez-Ineba A, Antonio P, Muro MD, Romeu A (2000) Persistent altered spermatogenesis in long-term childhood cancer survivors. Pediatr Hematol Oncol 17(1):21–30
Lustig RH, Hinds PS, Ringwald-Smith K, Christensen RK, Kaste SC, Schreiber RE, Rai SN, Lensing SY, Wu S, Xiong X (2003a) Octreotide therapy of pediatric hypothalamic obesity: a double-blind, placebo-controlled trial. J Clin Endocrinol Metab 88(6):2586–2592. https://doi.org/10.1210/jc.2002-030003
Lustig RH, Post SR, Srivannaboon K, Rose SR, Danish RK, Burghen GA, Xiong X, Wu S, Merchant TE (2003b) Risk factors for the development of obesity in children surviving brain tumors. J Clin Endocrinol Metab 88(2):611–616
Mackenzie S, Craven T, Gattamaneni HR, Swindell R, Shalet SM, Brabant G (2011) Long-term safety of growth hormone replacement after CNS irradiation. J Clin Endocrinol Metab 96(9):2756–2761. https://doi.org/10.1210/jc.2011-0112
Mandrell BN, Wise M, Schoumacher RA, Pritchard M, West N, Ness KK, Crabtree VM, Merchant TE, Morris B (2012) Excessive daytime sleepiness and sleep-disordered breathing disturbances in survivors of childhood central nervous system tumors. Pediatr Blood Cancer 58(5):746–751. https://doi.org/10.1002/pbc.23311
Mason PW, Krawiecki N, Meacham LR (2002) The use of dextroamphetamine to treat obesity and hyperphagia in children treated for craniopharyngioma. Arch Pediatr Adolesc Med 156(9):887–892
Merchant TE, Kiehna EN, Sanford RA, Mulhern RK, Thompson SJ, Wilson MW, Lustig RH, Kun LE (2002) Craniopharyngioma: the St. Jude Children’s Research Hospital experience 1984-2001. Int J Radiat Oncol Biol Phys 53(3):533–542
Merchant TE, Gould CJ, Xiong X, Robbins N, Zhu J, Pritchard DL, Khan R, Heideman RL, Krasin MJ, Kun LE (2004) Early neuro-otologic effects of three-dimensional irradiation in children with primary brain tumors. Int J Radiat Oncol Biol Phys 58(4):1194–1207
Merchant TE, Rose SR, Bosley C, Wu S, Xiong X, Lustig RH (2011) Growth hormone secretion after conformal radiation therapy in pediatric patients with localized brain tumors. J Clin Oncol 29(36):4776–4780. https://doi.org/10.1200/JCO.2011.37.9453
Mertens AC, Yasui Y, Neglia JP, Potter JD, Nesbit ME Jr, Ruccione K, Smithson WA, Robison LL (2001) Late mortality experience in five-year survivors of childhood and adolescent cancer: the Childhood Cancer Survivor Study. J Clin Oncol 19(13):3163–3172
Mertens AC, Liu Q, Neglia JP, Wasilewski K, Leisenring W, Armstrong GT, Robison LL, Yasui Y (2008) Cause-specific late mortality among 5-year survivors of childhood cancer: the Childhood Cancer Survivor Study. J Natl Cancer Inst 100(19):1368–1379. https://doi.org/10.1093/jnci/djn310
Metzger ML, Meacham LR, Patterson B, Casillas JS, Constine LS, Hijiya N, Kenney LB, Leonard M, Lockart BA, Likes W, Green DM (2013) Female reproductive health after childhood, adolescent, and young adult cancers: guidelines for the assessment and management of female reproductive complications. J Clin Oncol 31(9):1239–1247. https://doi.org/10.1200/JCO.2012.43.5511
Mike V, Meadows AT, D'Angio GJ (1982) Incidence of second malignant neoplasms in children: results of an international study. Lancet 2(8311):1326–1331
Mishra G, Chandrashekhar SR (2011) Management of diabetes insipidus in children. Ind J Endocrinol Metab 15(Suppl 3):S180–S187. https://doi.org/10.4103/2230-8210.84858
Moller TR, Garwicz S, Barlow L, Falck Winther J, Glattre E, Olafsdottir G, Olsen JH, Perfekt R, Ritvanen A, Sankila R, Tulinius H (2001) Decreasing late mortality among five-year survivors of cancer in childhood and adolescence: a population-based study in the Nordic countries. J Clin Oncol 19(13):3173–3181
Morris EB, Gajjar A, Okuma JO, Yasui Y, Wallace D, Kun LE, Merchant TE, Fouladi M, Broniscer A, Robison LL, Hudson MM (2007) Survival and late mortality in long-term survivors of pediatric CNS tumors. J Clin Oncol 25(12):1532–1538. https://doi.org/10.1200/JCO.2006.09.8194
Morris EB, Li C, Khan RB, Sanford RA, Boop F, Pinlac R, Xiong X, Merchant TE (2009) Evolution of neurological impairment in pediatric infratentorial ependymoma patients. J Neuro-Oncol 94(3):391–398. https://doi.org/10.1007/s11060-009-9866-8
Moskowitz CS, Malhotra J, Chou JF, Wolden SL, Weathers RE, Stovall M, Armstrong GT, Leisenring WM, Neglia JP, Robison LL, Oeffinger KC (2015) Breast cancer following spinal irradiation for a childhood cancer: a report from the Childhood Cancer Survivor Study. Radiother Oncol 117(2):213–216. https://doi.org/10.1016/j.radonc.2015.09.016. Epub 2015 Sep 18
Mostoufi-Moab S, Seidel K, Leisenring WM, Armstrong GT, Oeffinger KC, Stovall M, Meacham LR, Green DM, Weathers R, Ginsberg JP, Robison LL, Sklar CA (2016) Endocrine abnormalities in aging survivors of childhood cancer: a report from the Childhood Cancer Survivor Study. J Clin Oncol 34:3240–3247
Mueller S, Fullerton HJ, Stratton K, Leisenring W, Weathers RE, Stovall M, Armstrong GT, Goldsby RE, Packer RJ, Sklar CA, Bowers DC, Robison LL, Krull KR (2013) Radiation, atherosclerotic risk factors, and stroke risk in survivors of pediatric cancer: a report from the Childhood Cancer Survivor Study. Int J Radiat Oncol Biol Phys 86(4):649–655. https://doi.org/10.1016/j.ijrobp.2013.03.034
Mukherjee A, Tolhurst-Cleaver S, Ryder WD, Smethurst L, Shalet SM (2005) The characteristics of quality of life impairment in adult growth hormone (GH)-deficient survivors of cancer and their response to GH replacement therapy. J Clin Endocrinol Metab 90(3):1542–1549. https://doi.org/10.1210/jc.2004-0832
Muller HL (2014) Craniopharyngioma. Endocr Rev 35(3):513–543. https://doi.org/10.1210/er.2013-1115
Mulrooney DA, Ness KK, Neglia JP, Whitton JA, Green DM, Zeltzer LK, Robison LL, Mertens AC (2008) Fatigue and sleep disturbance in adult survivors of childhood cancer: a report from the childhood cancer survivor study (CCSS). Sleep 31(2):271–281
Murray RD, Darzy KH, Gleeson HK, Shalet SM (2002) GH-deficient survivors of childhood cancer: GH replacement during adult life. J Clin Endocrinol Metab 87(1):129–135. https://doi.org/10.1210/jcem.87.1.8146
Napoli C, Ignarro LJ (2009) Nitric oxide and pathogenic mechanisms involved in the development of vascular diseases. Arch Pharm Res 32(8):1103–1108. https://doi.org/10.1007/s12272-009-1801-1
Neglia JP, Friedman DL, Yasui Y, Mertens AC, Hammond S, Stovall M, Donaldson SS, Meadows AT, Robison LL (2001) Second malignant neoplasms in five-year survivors of childhood cancer: childhood cancer survivor study. J Natl Cancer Inst 93(8):618–629
Neglia JP, Robison LL, Stovall M, Liu Y, Packer RJ, Hammond S, Yasui Y, Kasper CE, Mertens AC, Donaldson SS, Meadows AT, Inskip PD (2006) New primary neoplasms of the central nervous system in survivors of childhood cancer: a report from the Childhood Cancer Survivor Study. J Natl Cancer Inst 98(21):1528–1537
Ness KK, Morris EB, Nolan VG, Howell CR, Gilchrist LS, Stovall M, Cox CL, Klosky JL, Gajjar A, Neglia JP (2010) Physical performance limitations among adult survivors of childhood brain tumors. Cancer 116(12):3034–3044. https://doi.org/10.1002/cncr.25051
Ness KK, Krull KR, Jones KE, Mulrooney DA, Armstrong GT, Green DM, Chemaitilly W, Smith WA, Wilson CL, Sklar CA, Shelton K, Srivastava DK, Ali S, Robison LL, Hudson MM (2013) Physiologic frailty as a sign of accelerated aging among adult survivors of childhood cancer: a report from the st jude lifetime cohort study. J Clin Oncol 31(36):4496–4503. https://doi.org/10.1200/JCO.2013.52.2268
Ning MS, Perkins SM, Dewees T, Shinohara ET (2015) Evidence of high mortality in long term survivors of childhood medulloblastoma. J Neuro-Oncol 122(2):321–327. https://doi.org/10.1007/s11060-014-1712-y
Noje C, Cohen K, Jordan LC (2013) Hemorrhagic and ischemic stroke in children with cancer. Pediatr Neurol 49(4):237–242. https://doi.org/10.1016/j.pediatrneurol.2013.04.009
Nolan VG, Gapstur R, Gross CR, Desain LA, Neglia JP, Gajjar A, Klosky JL, Merchant TE, Stovall M, Ness KK (2013) Sleep disturbances in adult survivors of childhood brain tumors. Qual Life Res 22(4):781–789. https://doi.org/10.1007/s11136-012-0208-5
Oberfield SE, Soranno D, Nirenberg A, Heller G, Allen JC, David R, Levine LS, Sklar CA (1996) Age at onset of puberty following high-dose central nervous system radiation therapy. Arch Pediatr Adolesc Med 150(6):589–592
Oeffinger KC, Mertens AC, Sklar CA, Kawashima T, Hudson MM, Meadows AT, Friedman DL, Marina N, Hobbie W, Kadan-Lottick NS, Schwartz CL, Leisenring W, Robison LL (2006) Chronic health conditions in adult survivors of childhood cancer. N Engl J Med 355(15):1572–1582
Ogilvy-Stuart AL, Shalet SM, Gattamaneni HR (1991) Thyroid function after treatment of brain tumors in children. J Pediatr 119(5):733–737
Ojemann JG, Hersonskey TY, Abeshaus S, Geyer JR, Saneto RP, Novotny EJ, Kollros P, Leary S, Holmes MD (2012) Epilepsy surgery after treatment of pediatric malignant brain tumors. Seizure 21(8):624–630. https://doi.org/10.1016/j.seizure.2012.07.003
Packer RJ, Boyett JM, Janss AJ, Stavrou T, Kun L, Wisoff J, Russo C, Geyer R, Phillips P, Kieran M, Greenberg M, Goldman S, Hyder D, Heideman R, Jones-Wallace D, August GP, Smith SH, Moshang T (2001) Growth hormone replacement therapy in children with medulloblastoma: use and effect on tumor control. J Clin Oncol 19(2):480–487
Packer RJ, Gurney JG, Punyko JA, Donaldson SS, Inskip PD, Stovall M, Yasui Y, Mertens AC, Sklar CA, Nicholson HS, Zeltzer LK, Neglia JP, Robison LL (2003) Long-term neurologic and neurosensory sequelae in adult survivors of a childhood brain tumor: childhood cancer survivor study. J Clin Oncol 21(17):3255–3261
Packer RJ, Zhou T, Holmes E, Vezina G, Gajjar A (2013) Survival and secondary tumors in children with medulloblastoma receiving radiotherapy and adjuvant chemotherapy: results of Children’s Oncology Group trial A9961. Neuro-Oncology 15(1):97–103. https://doi.org/10.1093/neuonc/nos267
Patterson BC, Chen Y, Sklar CA, Neglia J, Yasui Y, Mertens A, Armstrong GT, Meadows A, Stovall M, Robison LL, Meacham LR (2014) Growth hormone exposure as a risk factor for the development of subsequent neoplasms of the central nervous system: a report from the Childhood Cancer Survivor Study. J Clin Endocrinol Metab 99:2030–2037. https://doi.org/10.1210/jc.2013-4159
Pearce MS, Salotti JA, Little MP, McHugh K, Lee C, Kim KP, Howe NL, Ronckers CM, Rajaraman P, Sir Craft AW, Parker L, Berrington de Gonzalez A (2012) Radiation exposure from CT scans in childhood and subsequent risk of leukaemia and brain tumours: a retrospective cohort study. Lancet 380(9840):499–505. https://doi.org/10.1016/S0140-6736(12)60815-0
Perkins SM, Fei W, Mitra N, Shinohara ET (2013) Late causes of death in children treated for CNS malignancies. J Neuro-Oncol 115(1):79–85. https://doi.org/10.1007/s11060-013-1197-0
Peterson KM, Shao C, McCarter R, MacDonald TJ, Byrne J (2006) An analysis of SEER data of increasing risk of secondary malignant neoplasms among long-term survivors of childhood brain tumors. Pediatr Blood Cancer 47(1):83–88
Pietila S, Korpela R, Lenko HL, Haapasalo H, Alalantela R, Nieminen P, Koivisto AM, Makipernaa A (2012) Neurological outcome of childhood brain tumor survivors. J Neuro-Oncol 108(1):153–161. https://doi.org/10.1007/s11060-012-0816-5
Prados MD, Yung WK, Jaeckle KA, Robins HI, Mehta MP, Fine HA, Wen PY, Cloughesy TF, Chang SM, Nicholas MK, Schiff D, Greenberg HS, Junck L, Fink KL, Hess KR, Kuhn J (2004) Phase 1 trial of irinotecan (CPT-11) in patients with recurrent malignant glioma: a North American Brain Tumor Consortium study. Neuro-Oncology 6(1):44–54. https://doi.org/10.1215/S1152851703000292
Prayson RA (2010) Diagnostic challenges in the evaluation of chronic epilepsy-related surgical neuropathology. Am J Surg Pathol 34(5):e1–e13. https://doi.org/10.1097/PAS.0b013e3181d9ba38
Raman S, Grimberg A, Waguespack SG, Miller BS, Sklar CA, Meacham LR, Patterson BC (2015) Risk of neoplasia in pediatric patients receiving growth hormone therapy—a report from the Pediatric Endocrine Society Drug and Therapeutics Committee. J Clin Endocrinol Metab 100(6):2192–2203. https://doi.org/10.1210/jc.2015-1002
Ramelli GP, von der Weid N, Stanga Z, Mullis PE, Buergi U (1998) Suprasellar germinomas in childhood and adolescence: diagnostic pitfalls. J Pediatr Endocrinol Metab 11(6):693–697
Relling MV, Pui CH, Sandlund JT, Rivera GK, Hancock ML, Boyett JM, Schuetz EG, Evans WE (2000) Adverse effect of anticonvulsants on efficacy of chemotherapy for acute lymphoblastic leukaemia. Lancet 356(9226):285–290. https://doi.org/10.1016/S0140-6736(00)02503-4
Reulen RC, Winter DL, Frobisher C, Lancashire ER, Stiller CA, Jenney ME, Skinner R, Stevens MC, Hawkins MM (2010) Long-term cause-specific mortality among survivors of childhood cancer. JAMA 304(2):172–179. https://doi.org/10.1001/jama.2010.923
Ridola V, Fawaz O, Aubier F, Bergeron C, de Vathaire F, Pichon F, Orbach D, Gentet JC, Schmitt C, Dufour C, Oberlin O (2009) Testicular function of survivors of childhood cancer: a comparative study between ifosfamide- and cyclophosphamide-based regimens. Eur J Cancer 45(5):814–818. https://doi.org/10.1016/j.ejca.2009.01.002
Robbins ME, Zhao W (2004) Chronic oxidative stress and radiation-induced late normal tissue injury: a review. Int J Radiat Biol 80(4):251–259. https://doi.org/10.1080/09553000410001692726
Ron E, Modan B, Boice JD Jr, Alfandary E, Stovall M, Chetrit A, Katz L (1988) Tumors of the brain and nervous system after radiotherapy in childhood. N Engl J Med 319(16):1033–1039
Rose SR, Lustig RH, Pitukcheewanont P, Broome DC, Burghen GA, Li H, Hudson MM, Kun LE, Heideman RL (1999) Diagnosis of hidden central hypothyroidism in survivors of childhood cancer. J Clin Endocrinol Metab 84(12):4472–4479
Rose SR, Danish RK, Kearney NS, Schreiber RE, Lustig RH, Burghen GA, Hudson MM (2005) ACTH deficiency in childhood cancer survivors. Pediatr Blood Cancer 45(6):808–813. https://doi.org/10.1002/pbc.20327
Rosen G, Brand SR (2011) Sleep in children with cancer: case review of 70 children evaluated in a comprehensive pediatric sleep center. Support Care Cancer 19(7):985–994. https://doi.org/10.1007/s00520-010-0921-y
Ruda R, Soffietti R (2015) What is new in the management of epilepsy in gliomas? Curr Treat Options Neurol 17(6):351. https://doi.org/10.1007/s11940-015-0351-8
Ruda R, Bello L, Duffau H, Soffietti R (2012) Seizures in low-grade gliomas: natural history, pathogenesis, and outcome after treatments. Neuro-Oncology 14(Suppl 4):iv55–iv64. https://doi.org/10.1093/neuonc/nos199
Sala A, Barr RD (2007) Osteopenia and cancer in children and adolescents: the fragility of success. Cancer 109(7):1420–1431. https://doi.org/10.1002/cncr.22546
Saper CB (2013) The neurobiology of sleep. Continuum 19(1 Sleep Disorders):19–31. https://doi.org/10.1212/01.CON.0000427215.07715.73
Schmiegelow M, Lassen S, Poulsen HS, Feldt-Rasmussen U, Schmiegelow K, Hertz H, Muller J (2000) Cranial radiotherapy of childhood brain tumours: growth hormone deficiency and its relation to the biological effective dose of irradiation in a large population based study. Clin Endocrinol 53(2):191–197
Schmiegelow M, Lassen S, Poulsen HS, Schmiegelow K, Hertz H, Andersson AM, Skakkebaek NE, Muller J (2001) Gonadal status in male survivors following childhood brain tumors. J Clin Endocrinol Metab 86(6):2446–2452. https://doi.org/10.1210/jcem.86.6.7544
Schmiegelow M, Feldt-Rasmussen U, Rasmussen AK, Poulsen HS, Muller J (2003) A population-based study of thyroid function after radiotherapy and chemotherapy for a childhood brain tumor. J Clin Endocrinol Metab 88(1):136–140. https://doi.org/10.1210/jc.2002-020380
Schriock EA, Lustig RH, Rosenthal SM, Kaplan SL, Grumbach MM (1984) Effect of growth hormone (GH)-releasing hormone (GRH) on plasma GH in relation to magnitude and duration of GH deficiency in 26 children and adults with isolated GH deficiency or multiple pituitary hormone deficiencies: evidence for hypothalamic GRH deficiency. J Clin Endocrinol Metab 58(6):1043–1049. https://doi.org/10.1210/jcem-58-6-1043
Scott RM, Smith JL, Robertson RL, Madsen JR, Soriano SG, Rockoff MA (2004) Long-term outcome in children with moyamoya syndrome after cranial revascularization by pial synangiosis. J Neurosurg 100(2 Suppl Pediatrics):142–149. https://doi.org/10.3171/ped.2004.100.2.0142
Shalet SM, Gibson B, Swindell R, Pearson D (1987) Effect of spinal irradiation on growth. Arch Dis Child 62(5):461–464
Shuper A, Packer RJ, Vezina LG, Nicholson HS, Lafond D (1995) 'Complicated migraine-like episodes' in children following cranial irradiation and chemotherapy. Neurology 45(10):1837–1840
Silfen ME, Garvin JH Jr, Hays AP, Starkman HS, Aranoff GS, Levine LS, Feldstein NA, Wong B, Oberfield SE (2001) Primary central nervous system lymphoma in childhood presenting as progressive panhypopituitarism. J Pediatr Hematol Oncol 23(2):130–133
Sklar CA, Constine LS (1995) Chronic neuroendocrinological sequelae of radiation therapy. Int J Radiat Oncol Biol Phys 31(5):1113–1121
Sklar C, Sarafoglou K, Whittam E (1993) Efficacy of insulin-like growth factor binding protein 3 in predicting the growth hormone response to provocative testing in children treated with cranial irradiation. Acta Endocrinol 129(6):511–515
Sklar CA, Mertens AC, Mitby P, Occhiogrosso G, Qin J, Heller G, Yasui Y, Robison LL (2002) Risk of disease recurrence and second neoplasms in survivors of childhood cancer treated with growth hormone: a report from the Childhood Cancer Survivor Study. J Clin Endocrinol Metab 87(7):3136–3141
Sklar CA, Mertens AC, Mitby P, Whitton J, Stovall M, Kasper C, Mulder J, Green D, Nicholson HS, Yasui Y, Robison LL (2006) Premature menopause in survivors of childhood cancer: a report from the childhood cancer survivor study. J Natl Cancer Inst 98(13):890–896
Stavrou T, Bromley CM, Nicholson HS, Byrne J, Packer RJ, Goldstein AM, Reaman GH (2001) Prognostic factors and secondary malignancies in childhood medulloblastoma. J Pediatr Hematol Oncol 23(7):431–436
Stephen MD, Zage PE, Waguespack SG (2011) Gonadotropin-dependent precocious puberty: neoplastic causes and endocrine considerations. Int J Pediatr Endocrinol 2011:184502. https://doi.org/10.1155/2011/184502
Stewart FA, Heeneman S, Te Poele J, Kruse J, Russell NS, Gijbels M, Daemen M (2006) Ionizing radiation accelerates the development of atherosclerotic lesions in ApoE−/− mice and predisposes to an inflammatory plaque phenotype prone to hemorrhage. Am J Pathol 168(2):649–658. https://doi.org/10.2353/ajpath.2006.050409
Sugihara T, Hattori Y, Yamamoto Y, Qi F, Ichikawa R, Sato A, Liu MY, Abe K, Kanno M (1999) Preferential impairment of nitric oxide-mediated endothelium-dependent relaxation in human cervical arteries after irradiation. Circulation 100(6):635–641
Swerdlow AJ, Reddingius RE, Higgins CD, Spoudeas HA, Phipps K, Qiao Z, Ryder WD, Brada M, Hayward RD, Brook CG, Hindmarsh PC, Shalet SM (2000) Growth hormone treatment of children with brain tumors and risk of tumor recurrence. J Clin Endocrinol Metab 85(12):4444–4449. https://doi.org/10.1210/jcem.85.12.7044
Taylor DD, Potish RA (1985) Late deaths following radiotherapy for pediatric tumors. Am J Clin Oncol 8(6):472–476
Thomas BC, Stanhope R, Plowman PN, Leiper AD (1993) Growth following single fraction and fractionated total body irradiation for bone marrow transplantation. Eur J Pediatr 152(11):888–892
Tsui K, Gajjar A, Li C, Srivastava D, Broniscer A, Wetmore C, Kun LE, Merchant TE, Ellison DW, Orr BA, Boop FA, Klimo P, Ross J, Robison LL, Armstrong GT (2015) Subsequent neoplasms in survivors of childhood central nervous system tumors: risk after modern multimodal therapy. Neuro-Oncology 17(3):448–456. https://doi.org/10.1093/neuonc/nou279
Ullrich NJ, Robertson R, Kinnamon DD, Scott RM, Kieran MW, Turner CD, Chi SN, Goumnerova L, Proctor M, Tarbell NJ, Marcus KJ, Pomeroy SL (2007) Moyamoya following cranial irradiation for primary brain tumors in children. Neurology 68(12):932–938. https://doi.org/10.1212/01.wnl.0000257095.33125.48
Visser J, Hukin J, Sargent M, Steinbok P, Goddard K, Fryer C (2010) Late mortality in pediatric patients with craniopharyngioma. J Neuro-Oncol 100(1):105–111. https://doi.org/10.1007/s11060-010-0145-5
de Vries L, Horev G, Schwartz M, Phillip M (2006) Ultrasonographic and clinical parameters for early differentiation between precocious puberty and premature thelarche. Eur J Endocrinol 154(6):891–898. https://doi.org/10.1530/eje.1.02151
Weinzimer SA, Homan SA, Ferry RJ, Moshang T (1999) Serum IGF-I and IGFBP-3 concentrations do not accurately predict growth hormone deficiency in children with brain tumours. Clin Endocrinol 51(3):339–345
Wells EM, Gaillard WD, Packer RJ (2012) Pediatric brain tumors and epilepsy. Semin Pediatr Neurol 19(1):3–8. https://doi.org/10.1016/j.spen.2012.02.010
Whelan K, Stratton K, Kawashima T, Leisenring W, Hayashi S, Waterbor J, Blatt J, Sklar CA, Packer R, Mitby P, Robison LL, Mertens AC (2011) Auditory complications in childhood cancer survivors: a report from the childhood cancer survivor study. Pediatr Blood Cancer 57(1):126–134. https://doi.org/10.1002/pbc.23025
Wilne S, Collier J, Kennedy C, Koller K, Grundy R, Walker D (2007) Presentation of childhood CNS tumours: a systematic review and meta-analysis. Lancet Oncol 8(8):685–695. https://doi.org/10.1016/S1470-2045(07)70207-3
Yap KY, Chui WK, Chan A (2008) Drug interactions between chemotherapeutic regimens and antiepileptics. Clin Ther 30(8):1385–1407. https://doi.org/10.1016/j.clinthera.2008.08.011
Yuan C, Wu VW, Yip SP, Kwong DL, Ying M (2014) Predictors of the extent of carotid atherosclerosis in patients treated with radiotherapy for nasopharyngeal carcinoma. PLoS One 9(12):e116284. https://doi.org/10.1371/journal.pone.0116284
Yuan C, Yip SP, Wu VW, Kwong DL, Cheuk IW, Ying M (2015) Association between genetic polymorphisms and carotid atherosclerosis in patients treated with radiotherapy for nasopharyngeal carcinoma. Radiat Oncol 10:39. https://doi.org/10.1186/s13014-015-0341-8
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2018 Springer International Publishing AG, part of Springer Nature
About this chapter
Cite this chapter
Armstrong, G.T., Khan, R.B., Chemaitilly, W. (2018). Long-Term Outcomes Among Survivors of Childhood Central Nervous System Malignancies: Late Mortality, Subsequent Neoplasms, Endocrine and Neurologic Morbidity. In: Gajjar, A., Reaman, G., Racadio, J., Smith, F. (eds) Brain Tumors in Children. Springer, Cham. https://doi.org/10.1007/978-3-319-43205-2_15
Download citation
DOI: https://doi.org/10.1007/978-3-319-43205-2_15
Published:
Publisher Name: Springer, Cham
Print ISBN: 978-3-319-43203-8
Online ISBN: 978-3-319-43205-2
eBook Packages: MedicineMedicine (R0)